Narcolepsy and rapid eye movement sleep
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini +4 more
wiley +1 more source
Associations between selective serotonin reuptake inhibitors and adverse events following hip fracture arthroplasty: a retrospective cohort study. [PDF]
Lethbridge L +4 more
europepmc +1 more source
ABSTRACT Central disorders of hypersomnolence are characterised by excessive daytime sleepiness. There has been growing interest in analysing sleep micro‐architecture, to further understand how sleep is affected by these conditions. We investigated if sleep spindle activity differed between children with narcolepsy, idiopathic hypersomnolence (IH) and ...
Marisha Shetty +7 more
wiley +1 more source
Cardiac Valvular Incompetence Associated With Selective Serotonin Reuptake Inhibitors (SSRIs): A Disproportionality and Risk Factor Analysis From Global Safety Reports. [PDF]
Chan ACY, Han Y.
europepmc +1 more source
Concurrent Use of Tasipimidine Oral Solution and Fluoxetine in Dogs
ABSTRACT This exploratory randomized crossover study investigated pharmacokinetic interactions, functional alertness, and cardiovascular safety of tasipimidine oral solution administered alone and in combination with fluoxetine in healthy Beagle dogs (n = 8; 4 dogs per dose level), with a 7‐day washout between phases. Dogs received single oral doses of
Jenni Lindstedt +5 more
wiley +1 more source
Longitudinal metabolic profiling of women using selective serotonin reuptake inhibitors during pregnancy. [PDF]
Itkonen A +4 more
europepmc +1 more source
Evaluating the Effects of Selective Serotonin Reuptake Inhibitors on Osteogenesis of Periodontal Stem Cells: An In Vitro Study. [PDF]
Zeng Y, Li S, Jiang J.
europepmc +1 more source
The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations. [PDF]
Shaw J +6 more
europepmc +1 more source
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed +19 more
wiley +1 more source
Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
Levent Cerit
doaj +1 more source

